Cardiotrophin-1 and urocortin cause protection by the same pathway and hypertrophy via distinct pathways in cardiac myocytes

Cytokine

Volumn 17, Issue 5, 2002, Pages 243-253

  Railson, Julia E ^a   Liao, Zhihong ^a   Brar, Bhawanjit K ^a   Buddle, Joanna C ^b   Pennica, Diane ^c   Stephanou, Anastasis ^a   Latchman, David S ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c GENENTECH INC   (United States)

Author keywords

44 mitogen activated protein kinase; Cardiac hypertrophy; Cardiac protection; Cardiotrophin 1; MEK 1; P42; STAT1; STAT3; Urocortin

Indexed keywords

CARDIOTROPHIN 1; DNA; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN; PROTEIN P42; PROTEIN P44; STAT PROTEIN; UROCORTIN; CORTICOTROPIN RELEASING FACTOR; CYTOKINE; DNA BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NEUROPROTECTIVE AGENT; STAT3 PROTEIN; STAT3 PROTEIN, RAT; TRANSACTIVATOR PROTEIN;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL LEVEL; CELL SIZE; CONTROLLED STUDY; DNA DETERMINATION; DRUG EFFECT; DRUG MECHANISM; ENZYME INHIBITION; FEMALE; HEART HYPERTROPHY; HEART MUSCLE CELL; HEART PROTECTION; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; RAT; SIGNAL TRANSDUCTION; ANIMAL; CELL DEATH; CYTOLOGY; DOMINANT GENE; DOSE RESPONSE; GENETIC TRANSFECTION; HEART MUSCLE; HYPERTROPHY; METABOLISM; NICK END LABELING; PHYSIOLOGY; PLASMID; TIME;

ANIMALS; ANIMALS, NEWBORN; CELL DEATH; CELLS, CULTURED; CORTICOTROPIN-RELEASING HORMONE; CYTOKINES; DNA; DNA-BINDING PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; GENES, DOMINANT; HYPERTROPHY; IN SITU NICK-END LABELING; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; MYOCARDIUM; NEUROPROTECTIVE AGENTS; PLASMIDS; RATS; STAT3 TRANSCRIPTION FACTOR; TIME FACTORS; TRANS-ACTIVATORS; TRANSFECTION;

EID: 0035986842     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.2001.1011     Document Type: Article

References (42)

1. Cellular and signaling mechanisms of cardiac hypertrophy
2. Expression cloning of cardiotrophin 1, a cytokine that induces cardiac myocyte hypertrophy
3. Cardiotrophin-1 activates a distinct form of cardiac muscle cell hypertrophy. Assembly of sarcomeric units in series VIA gp130/leukemia inhibitory factor receptor-dependent pathways
4. Cardiotrophin-1, the new member of the interleukin-6 cytokine family
5. Interleukin-6 family of cytokines and gp130
6. Signalling of the cardiotrophin-1 receptor. Evidence for a third receptor component
7. Interleukin-6 type cytokine signalling through the gp130/Jak/STAT pathway
8. Cardiotrophin-1, a cytokine present in embryonic muscle, supports long-term survival of spinal motoneurons
9. Cardiotrophin-1 displays early expression in the murine heart tube and promotes cardiac myocyte survival
10. Cardiotrophin-1 induces heat shock protein accumulation in cultured cardiac cells and protects them from stressful stimuli
11. Cardiotrophin 1 (CT-1) inhibition of cardiac myocyte apoptosis via a mitogen-activated protein kinase-dependent pathway. Divergence from downstream CT-1 signals for myocardial cell hypertrophy
12. Cardiotrophin-1 increases angiotensinogen mRNA in rat cardiac myocytes through STAT3: An autocrine loop for hypertrophy
13. Cardiotrophin-1 phosphorylates Akt and BAD, and prolongs cell survival via a PI3K-dependent pathway in cardiac myocytes
14. Expression cloning of a human corticotropin-releasing-factor receptor
15. CRF2 alpha and CRF2 beta receptor mRNAs are differentially distributed between the rat central nervous system and peripheral tissues
16. Identification of a novel murine receptor for corticotropin-releasing hormone expressed in the heart
17. Cardiac inotropic actions of urocortin in conscious sheep
18. CRH-like peptides protect cardiac myocytes from lethal ischaemic injury
19. Expression and protective effects of urocortin in cardiac myocytes
20. Urocortin protects against ischemic and reperfusion injury via a MAPK-dependent pathway
21. Cardiotrophin-1 can protect cardiac myocytes from injury when added both prior to simulated ischaemia and at reoxygenation
22. Urocortin, a newly identified corticotropin-releasing factor-related mammalian peptide, stimulates atrial natriuretic peptide and brain natriuretic peptide secretions from neonatal rat cardiomyocytes
23. Regulation of cardiac gene expression during myocardial growth and hypertrophy: Molecular studies of an adaptive physiologic response
24. Urocortin, a member of the corticotropin-releasing factor family, in normal and diseased heart
25. Differentiation of rat myocytes in single cell cultures with and without proliferating nonmyocardial cells. Cross-striations, ultrastructure, and chronotropic response to isoproterenol
26. Isolation, characterization and adhesion of calcium-tolerant myocytes from the adult rat heart
27. Culturing of calcium stable adult cardiac myocytes
28. Inhibition of Stat1-mediated gene activation by PIAS1
29. Specific inhibition of Stat3 signal transduction by PIAS3
30. Cyclin D1 expression is regulated positively by the p42/p44MAPK and negatively by the p38/HOGMAPK pathway
31. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation
32. Phenylephrine, endothelin, prostaglandin F2alpha' and leukemia inhibitory factor induce different cardiac hypertrophy phenotypes in vitro
33. Ischemia-induced STAT-1 expression and activation play a critical role in cardiomyocyte apoptosis
34. In vivo effects of cardiotrophin-1
35. Augmented cardiac cardiotrophin-1 in experimental congestive heart failure
36. Ventricular expression of a MLC-2v-ras fusion gene induces cardiac hypertrophy and selective diastolic dysfunction in transgenic mice
37. Depletion of mitogen-activated protein kinase using an antisense oligodeoxynucleotide approach downregulates the phenylephrine-induced hypertrophic response in rat cardiac myocytes
38. Role of angiotensin II in activation of the JAK/STAT pathway induced by acute pressure overload in the rat heart
39. Mechanical stretch activates the JAK/STAT pathway in rat cardiomyocytes
40. Involvement of gp130-mediated signaling in pressure overload-induced activation of the JAK/STAT pathway in rodent heart
41. Signal transduction and activator of transcription (STAT) protein-dependent activation of angiotensinogen promoter: A cellular signal for hypertrophy in cardiac muscle
42. Activation of gp130 transduces hypertrophic signals via STAT3 in cardiac myocytes